Sangamo Therapeutics (SGMO) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -19.8%
Financial Fact:
Net loss: -18.97M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -19.8%
Financial Fact:
Net loss: -18.97M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q2 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $6.88 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roku Said To Be In Sale Talks, Including Possible Media Tie-up - Bloomberg
- Canterbury Park (CPHC) Declares $0.07 Quarterly Dividend; 1.8% Yield
- Iran deal reopens Strait of Hormuz - Reuters
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
